摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

12-bromo-5,6,7,8,13,14-hexahydro-7-methyl-2,3,9,10-bis(methylenedioxy)dibenz[c,g]azecine-8,14-dione | 952196-34-8

中文名称
——
中文别名
——
英文名称
12-bromo-5,6,7,8,13,14-hexahydro-7-methyl-2,3,9,10-bis(methylenedioxy)dibenz[c,g]azecine-8,14-dione
英文别名
24-Bromo-15-methyl-7,9,19,21-tetraoxa-15-azapentacyclo[15.7.0.04,12.06,10.018,22]tetracosa-1(24),4,6(10),11,17,22-hexaene-3,16-dione
12-bromo-5,6,7,8,13,14-hexahydro-7-methyl-2,3,9,10-bis(methylenedioxy)dibenz[c,g]azecine-8,14-dione化学式
CAS
952196-34-8
化学式
C20H16BrNO6
mdl
——
分子量
446.254
InChiKey
QMTNOJNJDLOVRV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    28
  • 可旋转键数:
    0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    74.3
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    12-bromo-5,6,7,8,13,14-hexahydro-7-methyl-2,3,9,10-bis(methylenedioxy)dibenz[c,g]azecine-8,14-dione 在 lithium aluminium tetrahydride 作用下, 以 四氢呋喃 为溶剂, 反应 15.0h, 以99%的产率得到Dihydroprotopine
    参考文献:
    名称:
    原生生物碱的合成
    摘要:
    为了合成原松碱生物碱,我们研究了基于单重氧合氧化茚并[2,1- a ] [3]苯并ze庚因的环扩大,然后转化所得的10元酰胺基的反应顺序。酮内酰胺成亚甲基,这是完成合成的最后一步。关键物质茚并[2,1- a ] [3]苯并ze庚因是通过Bischler-Napieralski环化烷氧基取代的1-(2-溴苄基)-3-苯并ze庚因-2-酮制备的。检查了该合成中取代基的立体效应。
    DOI:
    10.1021/jo071038y
  • 作为产物:
    描述:
    参考文献:
    名称:
    原生生物碱的合成
    摘要:
    为了合成原松碱生物碱,我们研究了基于单重氧合氧化茚并[2,1- a ] [3]苯并ze庚因的环扩大,然后转化所得的10元酰胺基的反应顺序。酮内酰胺成亚甲基,这是完成合成的最后一步。关键物质茚并[2,1- a ] [3]苯并ze庚因是通过Bischler-Napieralski环化烷氧基取代的1-(2-溴苄基)-3-苯并ze庚因-2-酮制备的。检查了该合成中取代基的立体效应。
    DOI:
    10.1021/jo071038y
点击查看最新优质反应信息

文献信息

  • On the Synthesis of Protopine Alkaloids
    作者:Yasuhiro Wada、Harumi Kaga、Shiho Uchiito、Eri Kumazawa、Miho Tomiki、Yu Onozaki、Nobuhito Kurono、Masao Tokuda、Takeshi Ohkuma、Kazuhiko Orito
    DOI:10.1021/jo071038y
    日期:2007.9.1
    For the synthesis of protopine alkaloids, we studied a reaction sequence based on a ring enlargement of indeno[2,1-a][3]benzazepines by a singlet oxygen oxygenation, followed by conversion of an amide carbonyl group of the resultant 10-membered keto-lactam to a methylene group, which is the last step for completion of the synthesis. The key substances, indeno[2,1-a][3]benzazepines, were prepared by
    为了合成原松碱生物碱,我们研究了基于单重氧合氧化茚并[2,1- a ] [3]苯并ze庚因的环扩大,然后转化所得的10元酰胺基的反应顺序。酮内酰胺成亚甲基,这是完成合成的最后一步。关键物质茚并[2,1- a ] [3]苯并ze庚因是通过Bischler-Napieralski环化烷氧基取代的1-(2-溴苄基)-3-苯并ze庚因-2-酮制备的。检查了该合成中取代基的立体效应。
查看更多

同类化合物

隐掌叶防己碱 隐品碱 紫菫醚 紫堇文碱 盐酸前鸦片碱 原阿片碱 别隐品碱 伪原阿片碱 5,7,8,15-四氢-4-羟基-3-甲氧基-6-甲基(1,3)苯并二氧戊环并(5,6-e)(2)苯并氮杂环癸烷-14(6H)-酮 1-甲氧基别隐品碱 3,4-dimethoxy-6-methyl-5,7,8,15-tetrahydro-6H-benzo[c][1,3]dioxolo[4',5':4,5]benz[1,2-g]azecin-14-one; hydrochloride tert-butyl (2S,3S)-2-(8-(benzyloxy)-1,5-dihydroxy-3-methyl-7,12-dioxobenzo[b]phenanthridin-6(5H,7H,12H)-yl)-3-methylpentanoate corycavidine corycavamine Corycavidine hydrochloride 5,6,7,8,13,14-hexahydro-7-methyl-2,3-dimethoxydibenzazecin-14-one 12-bromo-7-methyl-2,3,9,10-tetramethoxy-5,6,7,8,13,14-hexahydrodibenz[c,g]azecine-8,14-dione 12-bromo-5,6,7,8,13,14-hexahydro-7-methyl-2,3,9,10-bis(methylenedioxy)dibenz[c,g]azecine-8,14-dione Protopine-M (demethylene-methyl-) isomer-2, AC 7,8-dimethoxy-11-methyl-17,19-dioxa-11-azatetracyclo[12.7.0.04,9.016,20]henicosa-1(21),4(9),5,7,14,16(20)-hexaen-2-one;3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Protopine-M (demethylene-methyl-) isomer-1, AC 6-Hydroxy-allocryptopine (3R)-7,8-dimethoxy-3,11-dimethyl-17,19-dioxa-11-azatetracyclo[12.7.0.04,9.016,20]henicosa-1(21),4(9),5,7,14,16(20)-hexaen-2-one;(3S)-7,8-dimethoxy-3,11-dimethyl-17,19-dioxa-11-azatetracyclo[12.7.0.04,9.016,20]henicosa-1(21),4(9),5,7,14,16(20)-hexaen-2-one (2R)-2,15-dimethyl-7,9,19,21-tetraoxa-15-azapentacyclo[15.7.0.04,12.06,10.018,22]tetracosa-1(17),4,6(10),11,18(22),23-hexaen-3-one;(2S)-2,15-dimethyl-7,9,19,21-tetraoxa-15-azapentacyclo[15.7.0.04,12.06,10.018,22]tetracosa-1(17),4,6(10),11,18(22),23-hexaen-3-one 5,6,7,8,13,14-hexahydro-7-methyldibenzazecin-14-one 4-[[8-(4,5-dihydroxy-6-methyloxan-2-yl)oxy-1-hydroxy-5-methoxy-3-methyl-7,12-dioxo-5H-benzo[b]phenanthridin-6-yl]methyl]benzoic acid (±)-corycavidine (+/-)-corycavine 3-[[5-(carboxymethyl)-8-(4,5-dihydroxy-6-methyloxan-2-yl)oxy-1-hydroxy-3-methyl-7,12-dioxo-5H-benzo[b]phenanthridin-6-yl]methyl]benzoic acid 3-[[8-(4,5-dihydroxy-6-methyloxan-2-yl)oxy-1-hydroxy-5-methoxy-3-methyl-7,12-dioxo-5H-benzo[b]phenanthridin-6-yl]methyl]benzoic acid 13-oxocryptopine Coulteropin 3,10-dimethoxy-14H-benzo[e][2]benzazecin-13-one 6-Hydroxyprotopine 13-Oxo-muramin 4-[[8-(4,5-dihydroxy-6-methyloxan-2-yl)oxy-1,5-dihydroxy-3-methyl-7,12-dioxo-5H-benzo[b]phenanthridin-6-yl]methyl]benzoic acid 3,10-dihydroxy-14H-benzo[e][2]benzazecin-13-one 7,8,21-Trimethoxy-11-methyl-17,19-dioxa-11-azatetracyclo[12.7.0.04,9.016,20]henicosa-1(21),4(9),5,7,14,16(20)-hexaene-2,3-dione 4-[[5-(2-carboxy-2-oxoethyl)-8-(4,5-dihydroxy-6-methyloxan-2-yl)oxy-1-hydroxy-3-methyl-7,12-dioxo-5H-benzo[b]phenanthridin-6-yl]methyl]benzoic acid 4-Hydroxy-3,10,11-trimethoxy-6-methyl-5,7,8,14-tetrahydrobenzo[e][2]benzazecin-13-one 6,7-Dimethoxy-11-methyl-17,19-dioxa-11-azatetracyclo[12.7.0.04,9.016,20]henicosa-1(21),4,6,8,14,16(20)-hexaene-2,3-dione 7,8-Dihydroxy-11-methyl-17,19-dioxa-11-azatetracyclo[12.7.0.04,9.016,20]henicosa-1(21),4(9),5,7,14,16(20)-hexaen-2-one argemexicaine A 13-oxoprotopine 8-(4,5-dihydroxy-6-methyloxan-2-yl)oxy-1-hydroxy-5-methoxy-3-methyl-6-(2-oxopiperidin-3-yl)-5H-benzo[b]phenanthridine-7,12-dione 9-demethylallocryptopine 1,2-Dimethoxy-7-methyl-5H,6H,8H,11H,14H-benzo[1'',2''-4',5']azecino[9',8'-2,1]benzo[4,5-d]1,3-dioxolan-15-one 5,6-dihydro-3,5-di-O-methylconstrictosine leptocarpine 12-Methyl-6,8,18,20-tetraoxa-12-azahexacyclo[11.11.0.02,10.05,9.015,23.017,21]tetracosa-2(10),3,5(9),15,17(21),22-hexaen-24-one